ATE259654T1 - Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen - Google Patents

Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen

Info

Publication number
ATE259654T1
ATE259654T1 AT99927966T AT99927966T ATE259654T1 AT E259654 T1 ATE259654 T1 AT E259654T1 AT 99927966 T AT99927966 T AT 99927966T AT 99927966 T AT99927966 T AT 99927966T AT E259654 T1 ATE259654 T1 AT E259654T1
Authority
AT
Austria
Prior art keywords
prophylaxis
microorganisms
control
pharmaceutical preparations
surfaces infected
Prior art date
Application number
AT99927966T
Other languages
English (en)
Inventor
Pieter Jacob Swart
Maria Elizabeth Kuipers
Dirk Klaas Fokke Meijer
Robert Johan Joseph Hageman
Den Berg Jeroen Johannes M Van
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98203765A external-priority patent/EP0974360A3/de
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE259654T1 publication Critical patent/ATE259654T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT99927966T 1998-06-26 1999-06-28 Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen ATE259654T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL1009505 1998-06-26
NL1010284 1998-10-09
EP98203765A EP0974360A3 (de) 1998-06-26 1998-11-06 Pharmazeutische Präparate zur Bekämpfung oder Prophylaxe von Mikroorganismen infizierten Oberflächen
PCT/EP1999/004067 WO2000000214A2 (en) 1998-06-26 1999-06-28 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms

Publications (1)

Publication Number Publication Date
ATE259654T1 true ATE259654T1 (de) 2004-03-15

Family

ID=27239422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99927966T ATE259654T1 (de) 1998-06-26 1999-06-28 Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen

Country Status (8)

Country Link
EP (1) EP1089755B1 (de)
JP (1) JP2002519332A (de)
AT (1) ATE259654T1 (de)
AU (1) AU771077B2 (de)
CA (1) CA2332127A1 (de)
DE (1) DE69914911T2 (de)
NZ (1) NZ509101A (de)
WO (1) WO2000000214A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL363153A1 (en) * 2000-06-16 2004-11-15 Hercules Incorporated Chemically-modified antimicrobial peptides, compositions and methods of production and use
WO2001098540A2 (en) * 2000-06-22 2001-12-27 San Diego State University Foundation Recombination modulators and methods for their production and use
WO2002053185A2 (en) * 2001-01-05 2002-07-11 Intercell Ag Anti-inflammatory use of polycationic compounds
EP1347775B1 (de) 2001-01-05 2016-11-30 Valneva Austria GmbH Gebrauch von polykationischen substanzen als adjuvantien für impfstoffe
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
RU2305547C2 (ru) 2001-08-23 2007-09-10 Вестгейт Байолоджикал Лимитед Применение апопротеинов сыворотки молока в профилактике или лечении микробной или вирусной инфекции
PT1507554E (pt) * 2002-05-10 2011-11-21 Agennix Inc Lactoferrina no tratamento de neoplasmas malignos e outras doenças hiperproliferativas
WO2005016372A1 (en) * 2003-03-25 2005-02-24 Advitech Solutions Inc. Compositions comprising polymetal-binding proteins and plant extracts for reducing free radicals
EP1635766A4 (de) 2003-06-06 2009-09-30 Agennix Inc Lactoferrin als adjuvans in krebs-vakzinen
WO2007065128A2 (en) * 2005-11-30 2007-06-07 Auburn University Human alpha-defensins inhibit interleukin-1beta release
US9578891B2 (en) 2006-08-07 2017-02-28 Novozymes A/S Enzyme granules for animal feed
EP2051591B1 (de) * 2006-08-07 2016-04-20 Novozymes A/S Enzymgranulat für tierfutter
US20110306565A1 (en) * 2009-01-13 2011-12-15 Margit Mahlapuu Hyaluronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
FR2967160B1 (fr) 2010-11-09 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la dermatopontine et composition cosmetique les comprenant
WO2013076666A1 (en) * 2011-11-23 2013-05-30 Newsouth Innovations Pty Limited Antimicrobial peptides and uses thereof
CN108033995B (zh) * 2017-12-19 2020-12-29 渤海大学 两种来源于大黄鱼肌联蛋白的ace抑制肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69220397T2 (de) * 1991-03-13 1997-10-02 Morinaga Milk Industry Co Ltd Antimikrobielles Peptid und antimikrobieller Wirkstoff
EP0510912B1 (de) * 1991-04-24 1998-01-07 Morinaga Milk Industry Co., Ltd. Antimikrobielles Peptid und antimikrobieller Wirkstoff
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins

Also Published As

Publication number Publication date
JP2002519332A (ja) 2002-07-02
CA2332127A1 (en) 2000-01-06
AU771077B2 (en) 2004-03-11
EP1089755A2 (de) 2001-04-11
AU4512499A (en) 2000-01-17
NZ509101A (en) 2003-07-25
WO2000000214A3 (en) 2000-03-30
EP1089755B1 (de) 2004-02-18
DE69914911T2 (de) 2004-12-09
WO2000000214A2 (en) 2000-01-06
DE69914911D1 (de) 2004-03-25

Similar Documents

Publication Publication Date Title
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
AU3698697A (en) Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicament
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
BR9611565A (pt) Peptideo antimicrobiano, sistema de expressão recombinante para produçao de peptideo antimicrobiano, célula hospedeira recombinante ou progênie da mesma, composiçao farmacêutia e ambiental antimicrobiana, processo para produzir peptideo, para evitar o crescimento de um virus ou microbio, para inativar a endoxina de bacterias gram-negativas e para tratar o evitar a infecçao por micróbios ou virus em um induvìduo, e, anticorpos.
EP1377314A4 (de) Monoklonale antikörper gegen das clfa-protein und verfahren zur verwendung bei der behandlung bzw. pr vention von infektionen
ES2170239T3 (es) Peptidos antifungicos de d-aminoacidos basados en histatina.
DK0832119T3 (da) Histatinbaserede peptider mod svamp og bakterier
EP1283050A3 (de) Verbesserte Arzneimittelzusammensetzungen, welche ein bakterizides Permeabilität erhöhendes Protein enthalten
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
AU3657600A (en) Biologically active compounds of (ganoderma pfeifferi) dms 13239
BR9510423A (pt) Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana
ATE427116T1 (de) Behandlung von bakteriellen infektionen
WO1999063978A3 (en) Methods of treating microbial infection and therapeutic formulations therefor
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
DE69631381T2 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
WO2000012049A3 (en) A method for the treatment of staphylococcal disease
ATE78490T1 (de) Glykopeptid-antibiotika.
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
ATE261737T1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
MXPA03004005A (es) Uso de la pentraxima ptx3 de cadena larga para el tratamiento de enfermedades causadas por una activacion alterada del factor de crecimiento fgf-2.
ATE413170T1 (de) Medizinische zusammensetzung zur behandlung von infektionen mit arzneimittelresistentem staphylococcus aureus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties